Keyphrases
Veno-venous Extracorporeal Membrane Oxygenation (VV-ECMO)
46%
Extracorporeal Life Support
26%
Early Initiation
23%
Cardiac Surgery
23%
Meta-analysis
23%
Lung Compliance
23%
Electrical Impedance Tomography
23%
ARDS Network
23%
Clinically Significant
23%
Rotational Thromboelastometry (ROTEM)
23%
Effective Solutions
23%
Out-of-hospital Cardiac Arrest
23%
Cardiogenic Shock
23%
Transfusion Protocol
23%
Hemostasis
23%
Short-term Mortality
23%
Single-center Experience
23%
Transfusion
23%
PaO2
23%
Cardiopulmonary Resuscitation
23%
Intra-aortic Balloon Pump
23%
Aortic Valve Opening
23%
Protocol Analysis
23%
Clinical Implementation
23%
Venovenous Extracorporeal Life Support
23%
Survival Rate
15%
30-day Mortality
14%
PEEP Titration
11%
Clinical Impact
11%
Clinical Experience
11%
Left Ventricular Unloading
11%
Alveolar Recruitment
11%
Optimal PEEP
11%
Single Center
10%
Rethoracotomy
8%
Blood Products
8%
Return of Spontaneous Circulation
7%
Multicenter Randomized Controlled Trial
7%
Postcardiotomy
7%
Weaning Rate
7%
Neurological Status
7%
Cardiac Arrest
7%
Cost-effectiveness
7%
Event Rate
7%
Multicenter Trial
7%
Extracorporeal Membrane Oxygenation Support
7%
Observational Design
7%
Clinical Benefit
7%
Investigator-initiated
7%
Cardiac Surgery Patients
5%
Blood Loss
5%
INIS
patients
100%
surgery
46%
implementation
46%
membranes
46%
hospitals
43%
mortality
30%
design
25%
pumps
23%
valves
23%
closures
23%
transfusions
23%
electric impedance
23%
tomography
23%
solutions
23%
balloons
23%
refractories
23%
demand
23%
blood
15%
cardiopulmonary resuscitation
13%
emergencies
12%
algorithms
12%
cost
12%
implants
11%
unloading
11%
comparative evaluations
9%
lungs
9%
compliance
9%
adults
8%
losses
5%
hemostatics
5%
reduction
5%
length
5%
management
5%
Medicine and Dentistry
Extracorporeal Life Support
49%
Extracorporeal Membrane Oxygenation
46%
Heart Surgery
23%
Intra-Aortic Balloon Pump
23%
Thromboelastometry
23%
Blood Stasis
23%
Meta-Analysis
23%
Out of Hospital Cardiac Arrest
23%
Aortic Valve
23%
Resuscitation
23%
Survival Rate
15%
Hemodynamic
11%
Randomized Controlled Trial
10%
Blood Product
8%
Health Care Cost
8%
Thoracotomy
8%
Heart Arrest
7%
Return of Spontaneous Circulation
7%
Cost-Effectiveness Analysis
7%
Cardiogenic Shock
6%
Hemostat
5%
Bleeding
5%